Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Life-threatening hypoglycemia induced by a tyrosine kinase inhibitor in a patient with neuroendocrine tumor: A case report
Yenna Lee, Hye Seung Jung, Hyung Jin Choi, et al.
Diabetes Research and Clinical Practice (2011) Vol. 93, Iss. 2, pp. e68-e70
Closed Access | Times Cited: 20

Showing 20 citing articles:

Vascular and Metabolic Implications of Novel Targeted Cancer Therapies
Weijuan Li, Kevin Croce, David P. Steensma, et al.
Journal of the American College of Cardiology (2015) Vol. 66, Iss. 10, pp. 1160-1178
Open Access | Times Cited: 174
Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer
Anja Karlstaedt, Javid J. Moslehi, Rudolf A. de Boer
Nature Reviews Cardiology (2022) Vol. 19, Iss. 6, pp. 414-425
Open Access | Times Cited: 57
Kinase Inhibitors: Adverse Effects Related to the Endocrine System
Maya Lodish
The Journal of Clinical Endocrinology & Metabolism (2013) Vol. 98, Iss. 4, pp. 1333-1342
Open Access | Times Cited: 93
Malignant insulinoma: Recommendations for characterisation and treatment
Éric Baudin, Philippe Caron, Catherine Lombard‐Bohas, et al.
Annales d Endocrinologie (2013) Vol. 74, Iss. 5-6, pp. 523-533
Open Access | Times Cited: 63
The treatment of hyperinsulinemic hypoglycaemia in adults: an update
Maria Vittoria Davì, A. Pia, Valentina Guarnotta, et al.
Journal of Endocrinological Investigation (2016) Vol. 40, Iss. 1, pp. 9-20
Open Access | Times Cited: 50
Neuroendocrine tumors and diabetes mellitus: which treatment and which effect
Rossella Mazzilli, Virginia Zamponi, Camilla Mancini, et al.
Endocrine (2025)
Closed Access
Mechanisms through which diabetes mellitus influences renal cell carcinoma development and treatment: A review of the literature
Dominika Labochka, Barbara Moszczuk, Wojciech Kukwa, et al.
International Journal of Molecular Medicine (2016) Vol. 38, Iss. 6, pp. 1887-1894
Open Access | Times Cited: 37
Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors
P. Buffier, Benjamin Bouillet, Sarra Smati, et al.
Annales d Endocrinologie (2018) Vol. 79, Iss. 5, pp. 574-582
Closed Access | Times Cited: 26
Sunitinib-induced severe hypoglycemia in a diabetic patient
Ayşe Demirci, Öznur Bal, Ayşe Durnalı, et al.
Journal of Oncology Pharmacy Practice (2013) Vol. 20, Iss. 6, pp. 469-472
Closed Access | Times Cited: 18
Transformation of Nonfunctioning Pancreatic Neuroendocrine Carcinoma Cells into Insulin Producing Cells after Treatment with Sunitinib
Jung Hun Ohn, Yeong Gi Kim, Se‐Hoon Lee, et al.
Endocrinology and Metabolism (2013) Vol. 28, Iss. 2, pp. 149-149
Open Access | Times Cited: 15
Recommandations pour la prise en charge de l’insulinome malin
Éric Baudin, Philippe Caron, Catherine Lombard‐Bohas, et al.
La Presse Médicale (2014) Vol. 43, Iss. 6, pp. 645-659
Closed Access | Times Cited: 14
Severe resistant hypoglycemia in a patient with a pancreatic neuroendocrine tumor on sunitinib treatment
Athanasios Fountas, Stelios Tigas, Zoe Giotaki, et al.
HORMONES (2014)
Open Access | Times Cited: 12
The pharmacokinetics and hypoglycaemic effect of sunitinib in the diabetic rabbits
Edyta Szałek, Agnieszka Karbownik, Katarzyna Sobańska, et al.
Pharmacological Reports (2014) Vol. 66, Iss. 5, pp. 892-896
Closed Access | Times Cited: 12
Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?
Rashmi R. Shah
Drug Safety (2016) Vol. 40, Iss. 3, pp. 211-228
Closed Access | Times Cited: 11
Management of Acute Complications of Targeted Therapy in Patients With Cancer: A Review of Cases Managed in ICU
Aureliano Pistone, Valérie Durieux, Bogdan Grigoriu, et al.
Journal of Intensive Care Medicine (2018) Vol. 34, Iss. 6, pp. 435-448
Closed Access | Times Cited: 11
The influence of the time-of-day administration of the drug on the pharmacokinetics of sunitinib in rabbits.
Edyta Szałek, Agnieszka Karbownik, Katarzyna Sobańska, et al.
PubMed (2014) Vol. 18, Iss. 16, pp. 2393-9
Closed Access | Times Cited: 10
Recurrent Hypoglycemia Triggered by Sorafenib Therapy in a Patient with Hemangiopericytoma
Si Won Lee, Eun Kyung Lee, Tak Yun, et al.
Endocrinology and Metabolism (2014) Vol. 29, Iss. 2, pp. 202-202
Open Access | Times Cited: 6
Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype
Takaomi Kessoku, Noritoshi Kobayashi, Masato Yoneda, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 2
Hypoglycemic Coma in a Patient with Metastatic Renal Cell Carcinoma Treated with Sunitinib
Meyoung Cho, Hyeok Shim, Moo‐Rim Park
Korean Journal of Medicine (2014) Vol. 87, Iss. 4, pp. 501-501
Open Access | Times Cited: 1
Life threatening hypoglycaemia in a child with infantile myofibromatosis
Lenka Součková, Pavel Mazánek, Peter Múdry, et al.
Klinická farmakologie a farmacie (2018) Vol. 32, Iss. 2, pp. 33-37
Open Access | Times Cited: 1
Page 1

Scroll to top